Fua T - Search Results

1

Patient- and Clinician-Reported Outcomes in Human Papillomavirus-Associated Tonsillar Carcinoma Treated With Unilateral and Bilateral Intensity Modulated Radiation Therapy-A Substudy From TROG 12.01.

McDowell L, Rischin D, King M, Kenny L, Porceddu S, Wratten C, Macann A, Jackson JE, Bressel M, Fua T, Lin C, Liu C, Corry J. McDowell L, et al. Among authors: fua t. Int J Radiat Oncol Biol Phys. 2023 Jan 1;115(1):174-188. doi: 10.1016/j.ijrobp.2022.08.006. Epub 2022 Aug 10. Int J Radiat Oncol Biol Phys. 2023. PMID: 35961477

2

Intensity-modulated radiotherapy for nasopharyngeal carcinoma: clinical correlation of dose to the pharyngo-esophageal axis and dysphagia.

Fua TF, Corry J, Milner AD, Cramb J, Walsham SF, Peters LJ. Fua TF, et al. Int J Radiat Oncol Biol Phys. 2007 Mar 15;67(4):976-81. doi: 10.1016/j.ijrobp.2006.10.028. Epub 2007 Jan 17. Int J Radiat Oncol Biol Phys. 2007. PMID: 17234360

3

Phase 3 trial of domiciliary humidification to mitigate acute mucosal toxicity during radiation therapy for head-and-neck cancer: first report of Trans Tasman Radiation Oncology Group (TROG) 07.03 RadioHUM study.

Macann A, Fua T, Milross CG, Porceddu SV, Penniment M, Wratten C, Krawitz H, Poulsen M, Tang CI, Morton RP, Hay KD, Thomson V, Bell ML, King MT, Fraser-Browne CL, Hockey HU. Macann A, et al. Among authors: fua t. Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):572-9. doi: 10.1016/j.ijrobp.2013.11.226. Int J Radiat Oncol Biol Phys. 2014. PMID: 24521675 Clinical Trial.

4

Safety and cost analysis of an (18)FDG-PET-CT response based follow-up strategy for head and neck cancers treated with primary radiation or chemoradiation.

Shah K, Te Marvelde L, Collins M, De Abreu Lourenco R, D'Costa I, Coleman A, Fua T, Liu C, Rischin D, Lau E, Corry J. Shah K, et al. Among authors: fua t. Oral Oncol. 2015 May;51(5):529-35. doi: 10.1016/j.oraloncology.2015.02.005. Epub 2015 Mar 6. Oral Oncol. 2015. PMID: 25754169

5

Weekly cisplatin and radiotherapy for low risk, locoregionally advanced human papillomavirus-positive oropharyngeal squamous cell carcinoma.

Urban D, Corry J, Solomon B, Lim AM, Fua T, Coleman A, D'Costa I, Tiong A, Liu C, Peters LJ, Rischin D. Urban D, et al. Among authors: fua t. Head Neck. 2016 Apr;38 Suppl 1:E1117-21. doi: 10.1002/hed.24169. Epub 2015 Oct 13. Head Neck. 2016. PMID: 26461454

6

Prospective Study of Cetuximab, Carboplatin, and Radiation Therapy for Patients With Locally Advanced Head and Neck Squamous Cell Cancer Unfit for Cisplatin.

Corry J, Bressel M, Fua T, Herschtal A, Solomon B, Porceddu SV, Wratten C, Rischin D. Corry J, et al. Among authors: fua t. Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):948-954. doi: 10.1016/j.ijrobp.2017.02.088. Epub 2017 Feb 24. Int J Radiat Oncol Biol Phys. 2017. PMID: 28483336 Clinical Trial.

7

Outcomes of Routine Intensity Modulated Radiation Therapy Quality Assurance in a Large Head and Neck Cancer Center.

Amarasena I, Herschtal A, D'Costa I, Fua T, Tiong A, Geddes V, Tran P, Liu C, Corry J. Amarasena I, et al. Among authors: fua t. Int J Radiat Oncol Biol Phys. 2017 Jul 1;98(3):541-546. doi: 10.1016/j.ijrobp.2017.02.215. Epub 2017 Mar 4. Int J Radiat Oncol Biol Phys. 2017. PMID: 28581395

8

Prognostic Significance of PD-L1⁺ and CD8⁺ Immune Cells in HPV⁺ Oropharyngeal Squamous Cell Carcinoma.

Solomon B, Young RJ, Bressel M, Urban D, Hendry S, Thai A, Angel C, Haddad A, Kowanetz M, Fua T, Corry J, Fox S, Rischin D. Solomon B, et al. Among authors: fua t. Cancer Immunol Res. 2018 Mar;6(3):295-304. doi: 10.1158/2326-6066.CIR-17-0299. Epub 2018 Jan 29. Cancer Immunol Res. 2018. PMID: 29378694

9

Unilateral radiotherapy treatment for p16/human papillomavirus-positive squamous cell carcinoma of unknown primary in the head and neck.

Tiong A, Rischin D, Young RJ, Herschtal A, Solomon B, D'Costa I, Fua T, Liu C, Coleman A, Kleid S, Dixon BJ, Corry J. Tiong A, et al. Among authors: fua t. Laryngoscope. 2018 Sep;128(9):2076-2083. doi: 10.1002/lary.27131. Epub 2018 Feb 26. Laryngoscope. 2018. PMID: 29481710

10

A systematic review of the impact of outpatient clinical pharmacy services on medication-related outcomes in patients receiving anticancer therapies.

Maleki S, Alexander M, Fua T, Liu C, Rischin D, Lingaratnam S. Maleki S, et al. Among authors: fua t. J Oncol Pharm Pract. 2019 Jan;25(1):130-139. doi: 10.1177/1078155218783814. Epub 2018 Jun 25. J Oncol Pharm Pract. 2019. PMID: 29938594

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters